Odyssey Health (ODYY) Cash from Operations (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -0.09% |
| Oct 31, 2025 | -489.22% |
| Jul 31, 2025 | -1,104.67% |
| Apr 30, 2025 | 91.43% |
| Jan 31, 2025 | 81.22% |
| Oct 31, 2024 | -290.53% |
| Jul 31, 2024 | 65.44% |
| Apr 30, 2024 | 79.71% |
| Jan 31, 2024 | -1,414.91% |
| Oct 31, 2023 | 50.01% |
| Jul 31, 2023 | 27.91% |
| Apr 30, 2023 | 81.61% |
| Jan 31, 2023 | -217.48% |
| Oct 31, 2022 | -126.36% |
| Jul 31, 2022 | 211.35% |
| Apr 30, 2022 | -131.19% |
| Jan 31, 2022 | 63.99% |
| Oct 31, 2021 | -63.07% |
| Jul 31, 2021 | 61.31% |
| Apr 30, 2021 | -494.01% |
| Jan 31, 2021 | -2.44% |
| Oct 31, 2020 | 1.68% |
| Jul 31, 2020 | -1,081.95% |
| Apr 30, 2020 | 73.77% |
| Jan 31, 2020 | 53.64% |
| Oct 31, 2019 | -278.62% |
| Jul 31, 2019 | -93.26% |
| Apr 30, 2019 | -7,706.12% |
| Jan 31, 2019 | 97.95% |
| Oct 31, 2018 | 63.25% |
| Jul 31, 2018 | -1,567.60% |
| Apr 30, 2018 | 95.11% |
| Jan 31, 2018 | -93.86% |
| Oct 31, 2017 | 14.61% |
| Jul 31, 2017 | 61.08% |
| Apr 30, 2017 | -650.35% |
| Jan 31, 2017 | 1,201.78% |
| Oct 31, 2016 | 83.36% |
| Jul 31, 2016 | 54.23% |
| Apr 30, 2016 | -83.50% |
| Jan 31, 2016 | 42.53% |
| Oct 31, 2015 | -2,014.27% |
| Jul 31, 2015 | -119.20% |
| Apr 30, 2015 | -92.05% |
| Jan 31, 2015 | -50.05% |